Diana R Keith1, Cassandra A Stanton2,3, Diann E Gaalema4, Janice Y Bunn4,5, Nathan J Doogan6, Ryan Redner4,7, Allison N Kurti4, Antonio Cepeda-Benito8, Alexa A Lopez4, Adam L Morehead4, Megan E Roberts6, Stephen T Higgins4. 1. Vermont Center on Behavior and Health, Department of Psychiatry, University of Vermont, 1 South Prospect St. Rm 1415, Burlington, VT, 05403, USA. Diana.Keith@uvm.edu. 2. Westat, Rockville, MD, USA. 3. Department of Oncology, Georgetown University Medical Center/Cancer Prevention and Control Program, Washington, DC, USA. 4. Vermont Center on Behavior and Health, Department of Psychiatry, University of Vermont, 1 South Prospect St. Rm 1415, Burlington, VT, 05403, USA. 5. Department of Medical Biostatistics, University of Vermont, Burlington, VT, USA. 6. College of Public Health, The Ohio State University, Columbus, OH, USA. 7. Rehabilitation Institute, Southern Illinois University, Carbondale, IL, USA. 8. Department of Psychological Science, University of Vermont, Burlington, VT, USA.
Abstract
BACKGROUND: Disparities in tobacco use are worsening in the United States, disproportionately affecting those with chronic medical conditions. One possible contributor is that physicians may not screen and advise cessation uniformly across patients and/or tobacco products. OBJECTIVE: This study examined provider communications regarding cigarette and non-cigarette tobacco products among adults with chronic conditions. DESIGN: Cross-sectional study drawn from two waves (2013-2014) of the National Survey on Drug Use and Health (NSDUH). PARTICIPANTS: Adults (≥ 18 years) who used tobacco in the past year. MAIN MEASURES: Prevalence of tobacco use included past-year use of cigarettes, cigars, or smokeless tobacco among those with and without chronic conditions. Chronic conditions included asthma, anxiety, coronary heart disease, depression, diabetes, hepatitis, HIV, hypertension, lung cancer, stroke, and substance abuse. Odds ratio of receipt of screening and advice to quit across chronic condition and tobacco product type were reported. Data were analyzed using logistic regression, controlling for basic sociodemographic factors and number of provider visits. KEY RESULTS: Adults with anxiety, depression, and substance use disorders had the highest prevalence of past-year cigarette (37.2-58.2%), cigar (9.1-28.0%), and smokeless tobacco (3.1-11.7%) use. Patients with any chronic condition were more likely to receive advice to quit than those without a condition (OR 1.21-2.37, p < 0.01), although the odds were lowest among adults with mental health and substance use disorders (OR 1.21-1.35, p < 0.01). Cigarette smokers were more likely to report being screened and advised to quit than non-cigarette tobacco users (OR 1.54-5.71, p < 0.01). CONCLUSIONS: Results support the need for provider training to expand screening and cessation interventions to include the growing spectrum of tobacco products. Screening and referral to interventions are especially needed for those with mental health and substance use disorders to reduce the disparate burden of tobacco-related disease and death.
BACKGROUND: Disparities in tobacco use are worsening in the United States, disproportionately affecting those with chronic medical conditions. One possible contributor is that physicians may not screen and advise cessation uniformly across patients and/or tobacco products. OBJECTIVE: This study examined provider communications regarding cigarette and non-cigarette tobacco products among adults with chronic conditions. DESIGN: Cross-sectional study drawn from two waves (2013-2014) of the National Survey on Drug Use and Health (NSDUH). PARTICIPANTS: Adults (≥ 18 years) who used tobacco in the past year. MAIN MEASURES: Prevalence of tobacco use included past-year use of cigarettes, cigars, or smokeless tobacco among those with and without chronic conditions. Chronic conditions included asthma, anxiety, coronary heart disease, depression, diabetes, hepatitis, HIV, hypertension, lung cancer, stroke, and substance abuse. Odds ratio of receipt of screening and advice to quit across chronic condition and tobacco product type were reported. Data were analyzed using logistic regression, controlling for basic sociodemographic factors and number of provider visits. KEY RESULTS: Adults with anxiety, depression, and substance use disorders had the highest prevalence of past-year cigarette (37.2-58.2%), cigar (9.1-28.0%), and smokeless tobacco (3.1-11.7%) use. Patients with any chronic condition were more likely to receive advice to quit than those without a condition (OR 1.21-2.37, p < 0.01), although the odds were lowest among adults with mental health and substance use disorders (OR 1.21-1.35, p < 0.01). Cigarette smokers were more likely to report being screened and advised to quit than non-cigarette tobacco users (OR 1.54-5.71, p < 0.01). CONCLUSIONS: Results support the need for provider training to expand screening and cessation interventions to include the growing spectrum of tobacco products. Screening and referral to interventions are especially needed for those with mental health and substance use disorders to reduce the disparate burden of tobacco-related disease and death.
Entities:
Keywords:
chronic conditions; cigarettes; cigars; comorbidity; health disparities; physician advice; smokeless tobacco; tobacco use
Authors: Karin A Kasza; Bridget K Ambrose; Kevin P Conway; Nicolette Borek; Kristie Taylor; Maciej L Goniewicz; K Michael Cummings; Eva Sharma; Jennifer L Pearson; Victoria R Green; Annette R Kaufman; Maansi Bansal-Travers; Mark J Travers; Jonathan Kwan; Cindy Tworek; Yu-Ching Cheng; Ling Yang; Nikolas Pharris-Ciurej; Dana M van Bemmel; Cathy L Backinger; Wilson M Compton; Andrew J Hyland Journal: N Engl J Med Date: 2017-01-26 Impact factor: 91.245
Authors: Kenneth E Warner; Donald W Sexton; Brenda W Gillespie; David T Levy; Frank J Chaloupka Journal: Am J Public Health Date: 2013-11-14 Impact factor: 9.308
Authors: Richard A Goodman; Samuel F Posner; Elbert S Huang; Anand K Parekh; Howard K Koh Journal: Prev Chronic Dis Date: 2013-04-25 Impact factor: 2.830
Authors: Stephen P Fortmann; Steffani R Bailey; Neon B Brooks; Brian Hitsman; Sarah Stuart Rittner; Suzanne E Gillespie; Christian Nissen Hill; Michael C Leo; Phillip M Crawford; Weiming Hu; Dana S King; Conall O'Cleirigh; Jon Puro; Mary Ann McBurnie Journal: Health Serv Res Date: 2020-01-13 Impact factor: 3.402
Authors: Irene Pericot-Valverde; Rebecca J Elliott; Jeff S Priest; Trace Barret; Jin H Yoon; Charles C Miller; Chizimuzo T C Okoli; Ilana Haliwa; Philip A Ades; Diann E Gaalema Journal: Prev Med Date: 2019-06-27 Impact factor: 4.018
Authors: Diann E Gaalema; Hypatia A Bolívar; Sherrie Khadanga; Jeffrey S Priest; Stephen T Higgins; Philip A Ades Journal: Prev Med Date: 2020-09-08 Impact factor: 4.018
Authors: Hypatia A Bolívar; Rebecca J Elliott; William Middleton; Jin H Yoon; Chizimuzo T C Okoli; Ilana Haliwa; Charles C Miller; Philip A Ades; Diann E Gaalema Journal: J Cardiopulm Rehabil Prev Date: 2021-01-01 Impact factor: 3.646
Authors: Thulasee Jose; Joshua W Ohde; J Taylor Hays; Michael V Burke; David O Warner Journal: Int J Environ Res Public Health Date: 2020-06-06 Impact factor: 3.390